Eric Blanchard is a corporate finance lawyer whose practice consists principally of representing underwriters and issuers in capital markets transactions and advising management, boards of directors and shareholders on corporate governance and securities law matters. Representative Transactional Matters Investment-Grade Debt ˇ Represented a mega-cap global pharmaceutical firm in the issuance of investment-grade notes. ˇ Represented the underwriters in a 144A/Reg. S offering of investment-grade notes of a large-cap medical device firm in connection with a leveraged spin-off. ˇ Represented the underwriters in multiple public offerings of investment-grade notes of a large-cap financial services firm. ˇ Represented the underwriters in a public offering of investment-grade notes of a large-cap consumer goods firm. ˇ Represented the underwriters in multiple public and 144A offerings of investment-grade notes of a large-cap pharmaceutical distribution firm. Convertible Debt ˇ Represented a large-cap international media firm in an exchange of newly issued convertible notes for outstanding convertible notes conducted pursuant to Section 3(a)(9) of the Securities Act. ˇ Represented the underwriters in a public offering of convertible notes of a large-cap financial services firm. ˇ Represented a large-cap biotechnology firm in the issuance, and subsequent registration, of convertible notes. ˇ Represented the underwriters in a 144A/Reg. S offering of convertible notes of a Canadian biotechnology firm. Equity ˇ Represented the underwriters in the initial public offering of American Depositary Shares of a China-based biotechnology company, which involved the first listing of a China-based biotechnology company on Nasdaq. ˇ Represented the underwriters in the initial public offering, and subsequent follow-on equity offering, of class B common stock of a leading inter-dealer broker. ˇ Represented the underwriters in the initial public offering, and subsequent follow-on equity offering, of class A common stock of an electronic brokerage firm. ˇ Represented the underwriters in the initial public offering of common shares of a company developing neurostimulation therapies. ˇ Represented the underwriters in the initial public offering of common stock of an aesthetic laser company. High-yield Debt ˇ Represented a large-cap international media firm in a Rule 144A/Reg. S offering of senior secured notes. ˇ Represented a small-cap manufacturer of specialty steel products in a Rule 144A/Reg. S offering of senior secured notes. ˇ Represented a large-cap hospital firm in a Rule 144A/Reg. S offering of senior notes. Selected Activities ˇ SIFMA, Associate Member, Corporate Credit Markets Division Legal and Compliance Advisory Committee ˇ American Bar Association ˇ New York State Bar Association ˇ Association of the Bar of the City of New York ˇ Federal Bar Council |